Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Italy Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20115
20132
20142
20152
20164
20174
20188
20196
20217
20224
20235
20243
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting14
Terminated7
Active, not recruiting5
Unknown status4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated5
BioMarin Pharmaceutical4
GenSight Biologics4
Novartis Pharmaceuticals4
IRCCS Eugenio Medea3
Pfizer3
QED Therapeutics, a BridgeBio company3
Quince Therapeutics S.p.A.3
Forma Therapeutics, Inc.2
Genzyme, a Sanofi Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn62
Nervous System Diseases14
Musculoskeletal Diseases13
Hematologic Diseases12
Bone Diseases7
Blood Coagulation Disorders6
Coagulation Protein Disorders6
Hemoglobinopathies6
Hemorrhagic Disorders6
Neurodegenerative Diseases6

Trials

Showing 76 to 62 of 62. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.